Ratings UniCredit S.p.A. Börse Stuttgart

Equities

CRIN

IT0005239360

Real-time Estimate Tradegate 12:24:10 26/06/2024 pm IST 5-day change 1st Jan Change
35.05 EUR +0.57% Intraday chart for UniCredit S.p.A. +2.11% +41.95%

Strengths

  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • Its low valuation, with P/E ratio at 6.46 and 6.22 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
  • The company appears to be poorly valued given its net asset value.
  • The company is one of the best yield companies with high dividend expectations.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • As estimated by analysts, this group is among those businesses with the lowest growth prospects.
  • The average consensus view of analysts covering the stock has deteriorated over the past four months.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.

Ratings chart - Surperformance

Sector: Banks

1st Jan change Capi. Investor Rating ESG Refinitiv
+41.95% 61.41B -
+16.44% 569B
C+
+16.96% 308B
C+
+20.68% 259B
C+
+24.30% 188B
B-
+28.52% 172B
B-
+8.10% 160B
C+
-0.11% 156B
B-
+8.39% 150B
B-
+13.51% 143B
C+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes